Eero Rissanen Selected Research

KF18446

1/2021

Effect of dopaminergic medication on adenosine 2A receptor availability in patients with Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eero Rissanen Research Topics

Disease

9	Multiple Sclerosis 01/2022 - 06/2014
5	Inflammation (Inflammations) 01/2019 - 09/2013
3	Chronic Progressive Multiple Sclerosis 02/2021 - 09/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2022 - 01/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 10/2018
2	Disease Progression 01/2020 - 01/2018
2	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 10/2018 - 01/2014
1	Atrophy 12/2022
1	Weight Loss (Weight Reduction) 12/2022
1	Nervous System Diseases (Neurological Disorders) 12/2022
1	Autoimmune Diseases of the Nervous System 01/2022
1	Relapsing-Remitting Multiple Sclerosis 02/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Meningitis 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 11/2019
1	Brain Diseases (Brain Disorder) 10/2018
1	Infections 02/2018
1	Neutropenia 02/2018
1	Dementia (Dementias) 01/2018
1	Neuroinflammatory Diseases 04/2017
1	Encephalitis (Encephalitis, Rasmussen) 06/2014
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2014
1	Lewy Body Disease (Lewy Body Dementia) 01/2014
1	Poisoning 08/2010

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2014
5	Biomarkers (Surrogate Marker)IBA 12/2022 - 06/2014
2	Glial Fibrillary Acidic ProteinIBA 12/2022 - 01/2020
2	LigandsIBA 02/2021 - 06/2014
2	Fingolimod Hydrochloride (FTY720)FDA Link 02/2021 - 10/2017
2	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 01/2017
2	Rituximab (Mabthera)FDA Link 05/2020 - 02/2018
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 11/2019 - 01/2014
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022
1	Leucine (L-Leucine)FDA Link 01/2022
1	N- fluoroacetyl- N- (2,5- dimethoxybenzyl)- 2- phenoxyanilineIBA 02/2021
1	ocrelizumabIBA 01/2021
1	KF18446IBA 01/2021
1	AntibodiesIBA 05/2020
1	Dopamine (Intropin)FDA LinkGeneric 11/2019
1	Natalizumab (Tysabri)FDA Link 01/2019
1	14-3-3 Proteins (14-3-3 Protein)IBA 10/2018
1	SteroidsIBA 10/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2015
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 01/2014
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 09/2013
1	RacloprideIBA 08/2010
1	Levodopa (L Dopa)FDA LinkGeneric 08/2010

Therapy/Procedure

2	Therapeutics 01/2018 - 04/2017
1	Bariatric Surgery 12/2022
1	Immunotherapy 01/2022